Thai Ling Pharmaceuticals (01011.HK) plans to acquire approximately 116 million yuan to purchase 58.11% of the equity of Zhejiang Kangyuan Medical Devices.

Intelligent Finance APP News, Tai Ling Medicine (01011.HK) announced that on April 28, 2025, the company plans to acquire 100% of the issued shares of Junbinxiongdi Limited, Yue Hua Limited, and Zhong He Qun Lian Limited from Mr. Lou Yongbin, Mr. Lou Yongjun, Ms. Chen Hongli, Mr. Zhang Genhuo, Mr. Zhang Liliang, Ms. He Xianhua, Ms. Hu Baozhen, and Ms. Zheng Min for approximately RMB 116 million (equivalent to approximately HKD 123.6 million). The payment will be made in the form of newly issued shares at a price of HKD 0.45 per share, representing a discount of approximately 22.41% compared to the closing price of HKD 0.580 per share on the last trading day on the Stock Exchange.